Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03467724
Other study ID # CS0717
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 23, 2018
Est. completion date April 13, 2020

Study information

Verified date April 2023
Source Venus Concept
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Split-body/face evaluator-blind study of the safety and performance of fractional RF for the treatment of surgical scars following breast augmentation, abdominoplasty or face lift. The study will enroll up to 50 female subjects requesting treatment of surgical scars following breast augmentation or abdominoplasty and up to 25 male and female subjects requesting treatment of surgical scars following face lift surgery. Subjects will receive a total of three treatments of their surgical scars at one-month intervals on one side of the body or face only. Subjects will be followed up at one, two, three and ten months after their last treatment. Outcomes will be compared to the non-treated side.


Description:

Blinded evaluators to determine the efficacy of the study treatment by comparing baseline photographs with photographs taken at follow up months 3, 4, 5 and 12 using the Global Aesthetic Improvement scale (GAIS), Manchester Scar Scale (MSS) and Patient and Observer Scar assessment scale (POSAS). Study subjects will also complete a Patient and Observer Scar assessment scale (POSAS) and 5-Point Likert Satisfaction Scale at baseline and at follow-up month 5 and 12, indicating their satisfaction with the study treatment.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date April 13, 2020
Est. primary completion date April 13, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria: 1. Healthy, female, subjects 20-60 years of age who are seeking treatment for their breast augmentation or abdominoplasty surgical scars or male and female patients 40-75 years of age who are seeking treatment for their face lift surgical scars. 2. A minimum of four weeks since surgery. 3. Able to read, understand and voluntarily provide written Informed Consent. 4. Able and willing to comply with the treatment/follow-up schedule and requirements. 5. Willing to avoid direct sunlight for the duration of the study. 6. Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment and for the duration of the study, and have a negative Urine Pregnancy test at baseline. Exclusion Criteria: - 1. Fitzpatrick skin types 5-6. 2. Implantable defibrillators, cardiac pacemakers, and other metal implants 3. Subjects with any implantable metal device in the treatment area 4. Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body (e.g. cochlear implant). 5. Permanent implant in the treated area, such as metal plates and screws, or an injected chemical substance. 6. Current or history of any kind of cancer, or pre-malignant moles. 7. Severe concurrent conditions, such as cardiac disorders. 8. Pregnancy or intending to become pregnant during the study and nursing. 9. Impaired immune system due to immunosuppressive diseases, such as AIDS and HIV, or use of immunosuppressive medications. 10. History of diseases stimulated by heat, such as recurrent herpes simplex in the treatment area; may be enrolled only following a prophylactic regime. 11. Poorly controlled endocrine disorders, such as diabetes. 12. Any active condition in the treatment area, such as sores, psoriasis, eczema, and rash. 13. History of skin disorders, such as keloids, abnormal wound healing, as well as very dry and fragile skin. 14. History of bleeding coagulopathies, or use of anticoagulants. 15. Use of isotretinoin (Accutane®) within six months prior to treatment. 16. Treating over tattoo or permanent makeup. 17. Excessively tanned skin from sun, tanning beds or tanning creams within the last two weeks. 18. As per the practitioner's discretion, refrain from treating any condition which might make it unsafe for the patient.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
fractional radiofrequency
Fractional radiofrequency will be delivered to the area of the surgical scar identified to receive the study treatment.

Locations

Country Name City State
Spain Ocean Clinic Marbella

Sponsors (1)

Lead Sponsor Collaborator
Venus Concept

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Treating surgical scar tissue to improve appearance as evaluated by an independent blinded reviewer at 3 months and 10 months post treatment to assess the treatment efficacy. A blinded reviewer will analyze the photographs taken at baseline, at study visit 3 months from the study start and 10 months from study start to determine the efficacy of treatment using the 7-point General Aesthetic Improvement Scale (GAIS) where 3 is very much improved, 2 is much improved, 1 is improved, 0 is no change, -1 is worse, -2 is much worse and -3 is very much worse and the Manchester Scar Scale where the scar is evaluated by colour, surface appearance, contour, distortion and texture using a numbered scale. 3 months and 10 months post-treatment
Secondary Improvement in appearance of surgical scars at 1 and 2 months post-treatment Evaluated by the independent reviewer using the 7-point General Aesthetic Improvement Scale (GAIS) where 3 is very much improved, 2 is much improved, 1 is improved, 0 is no change, -1 is worse, -2 is much worse and -3 is very much worse and the Manchester Scar Scale where the scar is evaluated by colour, surface appearance, contour, distortion and texture using a numbered scale. 1 and 2 months
Secondary Assessment of surgical scars at 3 and 10 months post-treatment to assess the efficacy of treatment Patient and Observer Scar Assessment Scale (POSAS) will be used by the independent blinded reviewer to assess the efficacy of the treatment where the scar is evaluated on its vascularity, pigmentation, thickness, relief, pliability and surface area using a numbered scale. The subject will assess the scar with respect to pain, itching, color, stiffness, thickness and appearance compared to their normal skin using a numbered scale. 3 and 10 months post treatment
Secondary Subject satisfaction with treatment Subjects will use the 5-point Likert Satisfaction scale where 4 is very satisfied, 3 is satisfied, 2 is having no opinion, 1 is unsatisfied and 0 is very unsatisfied to evaluate their satisfaction with the treatment. 3 and 10 months post treatment
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06013514 - Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
Completed NCT00753922 - Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses Phase 3
Completed NCT01945463 - The Effect of Breast Augmentation on the Quality of Echocardiography Test N/A
Recruiting NCT05449587 - Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix
Completed NCT02302001 - Effects of Jet Hydro Dissection in Breast Augmentation Postoperative Pain N/A
Completed NCT00905645 - Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study N/A
Completed NCT00756652 - Mentor MemoryGel Post-Approval Study
Terminated NCT01870869 - NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study N/A
Completed NCT00684749 - A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation Mammaplasty N/A
Active, not recruiting NCT06079086 - Evaluation of the Clinical Evolution of Breast Increase Using Prostheses N/A
Active, not recruiting NCT03386682 - Evaluation of the Safety and Performance of ESTYME® MATRIX Round and Anatomical Breast Implants - EMMIE Study N/A
Completed NCT01146275 - A 7-year Follow up of All Subjects Incuded in Protocol 31GB0106 N/A
Completed NCT00663156 - A Prospective Study of Autologous Fat Grafting for Breast Augmentation N/A
Completed NCT00605670 - Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery N/A
Completed NCT01639755 - European New Texture Implant Clinical Experience With Shaped Breast Implants Phase 4
Completed NCT01639742 - European New Texture Implant Clinical Experience With Round Breast Implants N/A
Completed NCT04036487 - Effects of General Anesthesia on Quality of Recovery After Transaxillary Endoscopic Breast Augmentation N/A
Completed NCT01238601 - Upright Magnetic Resonance Imaging (MRI) Study - Breast Implant Shell Geometry and Edge Scalloping N/A
Completed NCT02235285 - Asian Outcomes of Primary Breast Augmentation N/A
Completed NCT00689871 - Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants N/A